Institutional Review Boards as Arbiters of Expanded Access to Unapproved Drugs: Time for a Change?
Crossref DOI link: https://doi.org/10.1177/2168479016628918
Published Online: 2016-12-30
Published Print: 2016-07
Update policy: https://doi.org/10.1177/sage-journals-update-policy
Redman, Barbara K.
Bateman-House, Alison Shea
Text and Data Mining valid from 2016-07-01